(Reuters) -Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve a lawsuit claiming they defrauded the state's Medicaid program ‌over alleged quality control lapses ...
According to the suit filed by Texas AG Ken Paxton in 2023, Pfizer (PFE) and Tris supplied an ADHD medication called Quillivant XR to children on Texas Medicaid despite the drug’s tendency to fail ...
GlobalData on MSN
Tris Pharma receives ex-US approvals for ADHD treatments
Tris Pharma has received additional ex-US approvals for its attention deficit hyperactivity disorder (ADHD) treatments, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results